Market Drivers:

The rising prevalence of osteoarthritis is estimated to enhance the osteoarthritis treatment market's growth. Injury, obesity, and a variety of other factors contribute to osteoarthritis. The damaged bodily part has severe joint pain and stiffness. Swelling of joints, tingling in the legs and limbs, and a reduction in range of motion are all indications of osteoarthritis. As per a study published in the Lancet Journal in November 2020, osteoarthritis affected about 7% of the global population, or more than 500 million people, in 2019, with women disproportionately affected. The number of people affected by osteoarthritis globally increased by 48 percent from 1990 to 2019, and osteoarthritis was the 15th leading cause of years lived with disability (YLDs) in 2019.